

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | omega-hydroxylase P450 pathway (GO:0097267) | 8.57257316 |
| 2 | epoxygenase P450 pathway (GO:0019373) | 8.50566442 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.66132655 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 7.66132655 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.33244672 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 7.33244672 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.96097671 |
| 8 | tryptophan catabolic process (GO:0006569) | 6.32576858 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 6.32576858 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 6.32576858 |
| 11 | oxidative demethylation (GO:0070989) | 6.32127281 |
| 12 | drug metabolic process (GO:0017144) | 6.26796228 |
| 13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.18770245 |
| 14 | kynurenine metabolic process (GO:0070189) | 6.13107595 |
| 15 | bile acid biosynthetic process (GO:0006699) | 6.01018455 |
| 16 | tryptophan metabolic process (GO:0006568) | 5.94555109 |
| 17 | glyoxylate metabolic process (GO:0046487) | 5.87939721 |
| 18 | urea cycle (GO:0000050) | 5.75703971 |
| 19 | urea metabolic process (GO:0019627) | 5.75703971 |
| 20 | S-adenosylmethionine metabolic process (GO:0046500) | 5.56768117 |
| 21 | cysteine metabolic process (GO:0006534) | 5.56740403 |
| 22 | alpha-linolenic acid metabolic process (GO:0036109) | 5.51607510 |
| 23 | negative regulation of fibrinolysis (GO:0051918) | 5.51429825 |
| 24 | sulfur amino acid catabolic process (GO:0000098) | 5.41844044 |
| 25 | high-density lipoprotein particle remodeling (GO:0034375) | 5.41075307 |
| 26 | phenylpropanoid metabolic process (GO:0009698) | 5.34304084 |
| 27 | regulation of fibrinolysis (GO:0051917) | 5.32585922 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 5.30303555 |
| 29 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.29594912 |
| 30 | protein carboxylation (GO:0018214) | 5.29594912 |
| 31 | complement activation, alternative pathway (GO:0006957) | 5.27729795 |
| 32 | regulation of protein activation cascade (GO:2000257) | 5.24558708 |
| 33 | ethanol metabolic process (GO:0006067) | 5.15673289 |
| 34 | bile acid metabolic process (GO:0008206) | 5.12147977 |
| 35 | aromatic amino acid family metabolic process (GO:0009072) | 5.08320582 |
| 36 | * serine family amino acid catabolic process (GO:0009071) | 5.03259940 |
| 37 | homocysteine metabolic process (GO:0050667) | 5.00613657 |
| 38 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.95962291 |
| 39 | regulation of complement activation (GO:0030449) | 4.89917856 |
| 40 | tyrosine metabolic process (GO:0006570) | 4.84187492 |
| 41 | regulation of cholesterol esterification (GO:0010872) | 4.78814036 |
| 42 | lysine metabolic process (GO:0006553) | 4.78573890 |
| 43 | lysine catabolic process (GO:0006554) | 4.78573890 |
| 44 | regulation of triglyceride catabolic process (GO:0010896) | 4.72422420 |
| 45 | * alpha-amino acid catabolic process (GO:1901606) | 4.70395252 |
| 46 | reverse cholesterol transport (GO:0043691) | 4.69573264 |
| 47 | regulation of plasminogen activation (GO:0010755) | 4.65302477 |
| 48 | plasma lipoprotein particle remodeling (GO:0034369) | 4.64520595 |
| 49 | protein-lipid complex remodeling (GO:0034368) | 4.64520595 |
| 50 | macromolecular complex remodeling (GO:0034367) | 4.64520595 |
| 51 | triglyceride homeostasis (GO:0070328) | 4.54519627 |
| 52 | acylglycerol homeostasis (GO:0055090) | 4.54519627 |
| 53 | cellular ketone body metabolic process (GO:0046950) | 4.52048820 |
| 54 | response to mercury ion (GO:0046689) | 4.51957887 |
| 55 | negative regulation of cholesterol transport (GO:0032375) | 4.50817941 |
| 56 | negative regulation of sterol transport (GO:0032372) | 4.50817941 |
| 57 | * amino-acid betaine metabolic process (GO:0006577) | 4.48101181 |
| 58 | indolalkylamine metabolic process (GO:0006586) | 4.47986746 |
| 59 | alkaloid metabolic process (GO:0009820) | 4.47614906 |
| 60 | bile acid and bile salt transport (GO:0015721) | 4.44698752 |
| 61 | phospholipid efflux (GO:0033700) | 4.43959061 |
| 62 | amine catabolic process (GO:0009310) | 4.40311754 |
| 63 | cellular biogenic amine catabolic process (GO:0042402) | 4.40311754 |
| 64 | coenzyme catabolic process (GO:0009109) | 4.37918248 |
| 65 | imidazole-containing compound metabolic process (GO:0052803) | 4.37333300 |
| 66 | cellular glucuronidation (GO:0052695) | 4.35955234 |
| 67 | * cellular amino acid catabolic process (GO:0009063) | 4.34813288 |
| 68 | negative regulation of blood coagulation (GO:0030195) | 4.34369745 |
| 69 | negative regulation of hemostasis (GO:1900047) | 4.34369745 |
| 70 | glutamate metabolic process (GO:0006536) | 4.30044487 |
| 71 | * glycine metabolic process (GO:0006544) | 4.27770248 |
| 72 | plasma lipoprotein particle clearance (GO:0034381) | 4.24905449 |
| 73 | * serine family amino acid metabolic process (GO:0009069) | 4.21157538 |
| 74 | serine family amino acid biosynthetic process (GO:0009070) | 4.18196393 |
| 75 | benzene-containing compound metabolic process (GO:0042537) | 4.17962220 |
| 76 | flavonoid metabolic process (GO:0009812) | 4.17872341 |
| 77 | cellular modified amino acid catabolic process (GO:0042219) | 4.17753634 |
| 78 | ethanol oxidation (GO:0006069) | 4.11935611 |
| 79 | arginine metabolic process (GO:0006525) | 4.09897657 |
| 80 | negative regulation of protein activation cascade (GO:2000258) | 4.09618781 |
| 81 | cholesterol efflux (GO:0033344) | 4.08486313 |
| 82 | regulation of humoral immune response (GO:0002920) | 4.08457533 |
| 83 | aldehyde catabolic process (GO:0046185) | 4.07539277 |
| 84 | drug catabolic process (GO:0042737) | 4.05086206 |
| 85 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.02146526 |
| 86 | fibrinolysis (GO:0042730) | 3.97675072 |
| 87 | intestinal cholesterol absorption (GO:0030299) | 3.97472487 |
| 88 | negative regulation of coagulation (GO:0050819) | 3.97250618 |
| 89 | low-density lipoprotein particle remodeling (GO:0034374) | 3.96511609 |
| 90 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.95240950 |
| 91 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.95240950 |
| 92 | sodium-independent organic anion transport (GO:0043252) | 3.92755260 |
| 93 | ketone body metabolic process (GO:1902224) | 3.91210713 |
| 94 | uronic acid metabolic process (GO:0006063) | 3.91064826 |
| 95 | glucuronate metabolic process (GO:0019585) | 3.91064826 |
| 96 | acute-phase response (GO:0006953) | 3.89492464 |
| 97 | negative regulation of wound healing (GO:0061045) | 3.87498169 |
| 98 | plasma lipoprotein particle assembly (GO:0034377) | 3.86917520 |
| 99 | blood coagulation, intrinsic pathway (GO:0007597) | 3.82977895 |
| 100 | * organic acid catabolic process (GO:0016054) | 3.81059077 |
| 101 | * carboxylic acid catabolic process (GO:0046395) | 3.81059077 |
| 102 | opsonization (GO:0008228) | 3.79064741 |
| 103 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.79040545 |
| 104 | short-chain fatty acid metabolic process (GO:0046459) | 3.78240761 |
| 105 | amino acid salvage (GO:0043102) | 3.77890622 |
| 106 | L-methionine salvage (GO:0071267) | 3.77890622 |
| 107 | L-methionine biosynthetic process (GO:0071265) | 3.77890622 |
| 108 | cofactor catabolic process (GO:0051187) | 3.76869876 |
| 109 | regulation of bile acid biosynthetic process (GO:0070857) | 3.76562696 |
| 110 | acetyl-CoA metabolic process (GO:0006084) | 3.74560219 |
| 111 | complement activation, classical pathway (GO:0006958) | 3.70079876 |
| 112 | cholesterol homeostasis (GO:0042632) | 3.69972139 |
| 113 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.69207431 |
| 114 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.69207431 |
| 115 | polyketide metabolic process (GO:0030638) | 3.68666038 |
| 116 | doxorubicin metabolic process (GO:0044598) | 3.68666038 |
| 117 | daunorubicin metabolic process (GO:0044597) | 3.68666038 |
| 118 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.68069332 |
| 119 | phospholipid homeostasis (GO:0055091) | 3.67583533 |
| 120 | negative regulation of lipase activity (GO:0060192) | 3.67015233 |
| 121 | complement activation (GO:0006956) | 3.66857858 |
| 122 | protein activation cascade (GO:0072376) | 3.66101326 |
| 123 | positive regulation of lipid catabolic process (GO:0050996) | 3.65855400 |
| 124 | xenobiotic metabolic process (GO:0006805) | 3.65449440 |
| 125 | urate metabolic process (GO:0046415) | 3.65329224 |
| 126 | sterol homeostasis (GO:0055092) | 3.64288909 |
| 127 | cytolysis (GO:0019835) | 3.63423604 |
| 128 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.62902744 |
| 129 | positive regulation of hemostasis (GO:1900048) | 3.62125938 |
| 130 | positive regulation of blood coagulation (GO:0030194) | 3.62125938 |
| 131 | heme transport (GO:0015886) | 3.62036261 |
| 132 | NAD biosynthetic process (GO:0009435) | 3.60659204 |
| 133 | regulation of cholesterol homeostasis (GO:2000188) | 3.60431894 |
| 134 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.57466177 |
| 135 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.57466177 |
| 136 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.54903486 |
| 137 | hormone catabolic process (GO:0042447) | 3.51213944 |
| 138 | exogenous drug catabolic process (GO:0042738) | 10.0642270 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.46253191 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.24491561 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.12737370 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.51350087 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.29761287 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.16129385 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.80780918 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.05916777 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.99932623 |
| 10 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.47449094 |
| 11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.06008059 |
| 12 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.02998578 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9944998 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.95030165 |
| 15 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.77554472 |
| 16 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.61897254 |
| 17 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.57494223 |
| 18 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.53414365 |
| 19 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.53401375 |
| 20 | VDR_22108803_ChIP-Seq_LS180_Human | 1.52276583 |
| 21 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.45061538 |
| 22 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.41546830 |
| 23 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40521566 |
| 24 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.39552152 |
| 25 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.38728167 |
| 26 | GATA1_22025678_ChIP-Seq_K562_Human | 1.34572795 |
| 27 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.31108935 |
| 28 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.27442631 |
| 29 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.26457584 |
| 30 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.24188136 |
| 31 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.23575759 |
| 32 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.22365752 |
| 33 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.20667970 |
| 34 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.20484408 |
| 35 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.19136673 |
| 36 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.16436719 |
| 37 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.14628865 |
| 38 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.14169101 |
| 39 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.13852078 |
| 40 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.13512621 |
| 41 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.13382950 |
| 42 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.11729080 |
| 43 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.08626330 |
| 44 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.08626330 |
| 45 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.07951059 |
| 46 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.06450150 |
| 47 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.06450150 |
| 48 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.06204755 |
| 49 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.05584537 |
| 50 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.03887880 |
| 51 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.03138512 |
| 52 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.02462995 |
| 53 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.02384901 |
| 54 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.00760157 |
| 55 | NFYA_21822215_ChIP-Seq_K562_Human | 1.00696701 |
| 56 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.99506426 |
| 57 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.99430385 |
| 58 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98303191 |
| 59 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.97094788 |
| 60 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.97094788 |
| 61 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.96833574 |
| 62 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.96223731 |
| 63 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95872420 |
| 64 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.95832793 |
| 65 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.95557649 |
| 66 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.95441623 |
| 67 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.94436745 |
| 68 | NCOR_22424771_ChIP-Seq_293T_Human | 0.94261097 |
| 69 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.93560571 |
| 70 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.89696285 |
| 71 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.89446742 |
| 72 | NFYB_21822215_ChIP-Seq_K562_Human | 0.88865865 |
| 73 | P300_19829295_ChIP-Seq_ESCs_Human | 0.88413420 |
| 74 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.87569726 |
| 75 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.87555634 |
| 76 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.87473745 |
| 77 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.86841131 |
| 78 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.86800301 |
| 79 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.86762395 |
| 80 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.86139668 |
| 81 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.85094837 |
| 82 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.85052050 |
| 83 | TCF4_23295773_ChIP-Seq_U87_Human | 0.84617335 |
| 84 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.84445631 |
| 85 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.84435271 |
| 86 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.83723572 |
| 87 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.83675336 |
| 88 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.83666599 |
| 89 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.83062403 |
| 90 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.82743709 |
| 91 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.81889638 |
| 92 | AR_25329375_ChIP-Seq_VCAP_Human | 0.81877776 |
| 93 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.81338141 |
| 94 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.81240152 |
| 95 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.80545268 |
| 96 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.80339900 |
| 97 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.80182645 |
| 98 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.77114252 |
| 99 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.75804618 |
| 100 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.73551428 |
| 101 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.72042466 |
| 102 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.71622002 |
| 103 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.69584699 |
| 104 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.68398700 |
| 105 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.67723651 |
| 106 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.65980899 |
| 107 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.65784158 |
| 108 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.65601178 |
| 109 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.65370806 |
| 110 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.64937940 |
| 111 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63880350 |
| 112 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.63639367 |
| 113 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.62819752 |
| 114 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.61463956 |
| 115 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.61463956 |
| 116 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.59224136 |
| 117 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.57851693 |
| 118 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.56368351 |
| 119 | AR_20517297_ChIP-Seq_VCAP_Human | 0.55593127 |
| 120 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.54778717 |
| 121 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.53744200 |
| 122 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.53095534 |
| 123 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.52380620 |
| 124 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51852066 |
| 125 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.51544384 |
| 126 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.51214943 |
| 127 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.50868070 |
| 128 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.50363856 |
| 129 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.50014247 |
| 130 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.49710588 |
| 131 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.47881405 |
| 132 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47705106 |
| 133 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.46971756 |
| 134 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.46863134 |
| 135 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.46599624 |
| 136 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.45081419 |
| 137 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45025607 |
| 138 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.44780343 |
| 139 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.44674211 |
| 140 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.44349949 |
| 141 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.40865293 |
| 142 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.40452902 |
| 143 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.39581324 |
| 144 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.39396377 |
| 145 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.39212397 |
| 146 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.38947017 |
| 147 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.37284082 |
| 148 | GATA2_19941826_ChIP-Seq_K562_Human | 0.37256983 |
| 149 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.36946081 |
| 150 | GATA1_19941826_ChIP-Seq_K562_Human | 0.36928267 |
| 151 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.36621624 |
| 152 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.36358389 |
| 153 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.35923387 |
| 154 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.35369641 |
| 155 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.35212479 |
| 156 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.35204744 |
| 157 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.35040743 |
| 158 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.34290768 |
| 159 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.34138315 |
| 160 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.34019134 |
| 161 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.33987113 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.30480627 |
| 2 | MP0005360_urolithiasis | 7.67351311 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.43010229 |
| 4 | MP0005365_abnormal_bile_salt | 6.14370961 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.15366257 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.26472721 |
| 7 | MP0003252_abnormal_bile_duct | 3.89970911 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.51623223 |
| 9 | MP0009840_abnormal_foam_cell | 3.19974323 |
| 10 | MP0005083_abnormal_biliary_tract | 2.97996921 |
| 11 | MP0003195_calcinosis | 2.92446016 |
| 12 | MP0005332_abnormal_amino_acid | 2.92035346 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.55821396 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.29530625 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.20374234 |
| 16 | MP0000609_abnormal_liver_physiology | 2.13699024 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.07604692 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.05556791 |
| 19 | MP0003868_abnormal_feces_composition | 1.95018054 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.84824925 |
| 21 | MP0001764_abnormal_homeostasis | 1.73527004 |
| 22 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.58536835 |
| 23 | MP0009697_abnormal_copulation | 1.57271946 |
| 24 | MP0005451_abnormal_body_composition | 1.57053402 |
| 25 | MP0003011_delayed_dark_adaptation | 1.38469252 |
| 26 | MP0009643_abnormal_urine_homeostasis | 1.33933432 |
| 27 | MP0003186_abnormal_redox_activity | 1.33444306 |
| 28 | MP0003656_abnormal_erythrocyte_physiolo | 1.22288969 |
| 29 | MP0000598_abnormal_liver_morphology | 1.16907945 |
| 30 | MP0005647_abnormal_sex_gland | 1.13883843 |
| 31 | MP0009764_decreased_sensitivity_to | 1.08174516 |
| 32 | MP0005636_abnormal_mineral_homeostasis | 1.02771834 |
| 33 | MP0009763_increased_sensitivity_to | 1.00085913 |
| 34 | MP0000604_amyloidosis | 0.99846514 |
| 35 | MP0003705_abnormal_hypodermis_morpholog | 0.98621352 |
| 36 | MP0002254_reproductive_system_inflammat | 0.96349949 |
| 37 | MP0008469_abnormal_protein_level | 0.91072937 |
| 38 | MP0005408_hypopigmentation | 0.89315672 |
| 39 | MP0009642_abnormal_blood_homeostasis | 0.88297223 |
| 40 | MP0006036_abnormal_mitochondrial_physio | 0.87524047 |
| 41 | MP0010368_abnormal_lymphatic_system | 0.87159668 |
| 42 | MP0002876_abnormal_thyroid_physiology | 0.86482887 |
| 43 | MP0005084_abnormal_gallbladder_morpholo | 0.86245004 |
| 44 | MP0005670_abnormal_white_adipose | 0.79322026 |
| 45 | MP0005376_homeostasis/metabolism_phenot | 0.79263344 |
| 46 | MP0009765_abnormal_xenobiotic_induced | 0.77968104 |
| 47 | MP0001661_extended_life_span | 0.76128674 |
| 48 | MP0002078_abnormal_glucose_homeostasis | 0.75612811 |
| 49 | MP0005551_abnormal_eye_electrophysiolog | 0.72811084 |
| 50 | MP0003879_abnormal_hair_cell | 0.72080261 |
| 51 | MP0002971_abnormal_brown_adipose | 0.70901390 |
| 52 | MP0005220_abnormal_exocrine_pancreas | 0.70215848 |
| 53 | MP0001756_abnormal_urination | 0.69067714 |
| 54 | MP0005535_abnormal_body_temperature | 0.68839846 |
| 55 | MP0005334_abnormal_fat_pad | 0.66899356 |
| 56 | MP0009053_abnormal_anal_canal | 0.62993851 |
| 57 | MP0005266_abnormal_metabolism | 0.62429870 |
| 58 | MP0006035_abnormal_mitochondrial_morpho | 0.61564902 |
| 59 | MP0003690_abnormal_glial_cell | 0.61364271 |
| 60 | MP0004130_abnormal_muscle_cell | 0.61046078 |
| 61 | MP0003718_maternal_effect | 0.58738055 |
| 62 | MP0005187_abnormal_penis_morphology | 0.58544052 |
| 63 | MP0000639_abnormal_adrenal_gland | 0.56512892 |
| 64 | MP0003329_amyloid_beta_deposits | 0.55747859 |
| 65 | MP0003646_muscle_fatigue | 0.55719215 |
| 66 | MP0004381_abnormal_hair_follicle | 0.55682009 |
| 67 | MP0002282_abnormal_trachea_morphology | 0.55351360 |
| 68 | MP0001986_abnormal_taste_sensitivity | 0.54828693 |
| 69 | MP0005395_other_phenotype | 0.54112973 |
| 70 | MP0002136_abnormal_kidney_physiology | 0.53963124 |
| 71 | MP0004142_abnormal_muscle_tone | 0.51950848 |
| 72 | MP0005464_abnormal_platelet_physiology | 0.50906385 |
| 73 | MP0005448_abnormal_energy_balance | 0.50486110 |
| 74 | MP0003724_increased_susceptibility_to | 0.48502746 |
| 75 | MP0003638_abnormal_response/metabolism_ | 0.48242611 |
| 76 | MP0002928_abnormal_bile_duct | 0.46973128 |
| 77 | MP0004782_abnormal_surfactant_physiolog | 0.44434592 |
| 78 | MP0009785_altered_susceptibility_to | 0.44365434 |
| 79 | MP0008874_decreased_physiological_sensi | 0.44090727 |
| 80 | MP0008873_increased_physiological_sensi | 0.43508099 |
| 81 | MP0002822_catalepsy | 0.43437537 |
| 82 | MP0003436_decreased_susceptibility_to | 0.42726649 |
| 83 | MP0010386_abnormal_urinary_bladder | 0.41679798 |
| 84 | MP0003953_abnormal_hormone_level | 0.40570584 |
| 85 | MP0003959_abnormal_lean_body | 0.40408300 |
| 86 | MP0001944_abnormal_pancreas_morphology | 0.39424837 |
| 87 | MP0005377_hearing/vestibular/ear_phenot | 0.38367682 |
| 88 | MP0003878_abnormal_ear_physiology | 0.38367682 |
| 89 | MP0001984_abnormal_olfaction | 0.38182656 |
| 90 | MP0002234_abnormal_pharynx_morphology | 0.37576283 |
| 91 | MP0005248_abnormal_Harderian_gland | 0.37316058 |
| 92 | MP0009672_abnormal_birth_weight | 0.36062277 |
| 93 | MP0008872_abnormal_physiological_respon | 0.36041974 |
| 94 | MP0002909_abnormal_adrenal_gland | 0.35985792 |
| 95 | MP0000579_abnormal_nail_morphology | 0.35861733 |
| 96 | MP0003075_altered_response_to | 0.35547201 |
| 97 | MP0008961_abnormal_basal_metabolism | 0.35449326 |
| 98 | MP0005666_abnormal_adipose_tissue | 0.35120037 |
| 99 | MP0005166_decreased_susceptibility_to | 0.34982453 |
| 100 | MP0000230_abnormal_systemic_arterial | 0.34685788 |
| 101 | MP0002796_impaired_skin_barrier | 0.34100480 |
| 102 | MP0006082_CNS_inflammation | 0.33788106 |
| 103 | MP0005379_endocrine/exocrine_gland_phen | 0.33261747 |
| 104 | MP0005646_abnormal_pituitary_gland | 0.32774126 |
| 105 | MP0002168_other_aberrant_phenotype | 0.32669193 |
| 106 | MP0001853_heart_inflammation | 0.31534677 |
| 107 | MP0009115_abnormal_fat_cell | 0.31076217 |
| 108 | MP0004043_abnormal_pH_regulation | 0.30285334 |
| 109 | MP0002837_dystrophic_cardiac_calcinosis | 0.29671764 |
| 110 | MP0001845_abnormal_inflammatory_respons | 0.29155448 |
| 111 | MP0009384_cardiac_valve_regurgitation | 0.29087067 |
| 112 | MP0002135_abnormal_kidney_morphology | 0.29053798 |
| 113 | MP0000249_abnormal_blood_vessel | 0.28864056 |
| 114 | MP0002638_abnormal_pupillary_reflex | 0.28362325 |
| 115 | MP0008775_abnormal_heart_ventricle | 0.28036519 |
| 116 | MP0002970_abnormal_white_adipose | 0.27684312 |
| 117 | MP0005058_abnormal_lysosome_morphology | 0.27292824 |
| 118 | MP0001243_abnormal_dermal_layer | 0.26797204 |
| 119 | MP0001915_intracranial_hemorrhage | 0.26533452 |
| 120 | MP0004883_abnormal_blood_vessel | 0.26087792 |
| 121 | MP0001765_abnormal_ion_homeostasis | 0.26066668 |
| 122 | MP0002069_abnormal_eating/drinking_beha | 0.25619458 |
| 123 | MP0002132_abnormal_respiratory_system | 0.25598792 |
| 124 | MP0001881_abnormal_mammary_gland | 0.25046519 |
| 125 | MP0005645_abnormal_hypothalamus_physiol | 0.23898343 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.42534158 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.24602010 |
| 3 | Deep venous thrombosis (HP:0002625) | 7.22955307 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.69426471 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.50312762 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.29405787 |
| 7 | Xanthomatosis (HP:0000991) | 6.19450551 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.47708093 |
| 9 | Complement deficiency (HP:0004431) | 5.23388284 |
| 10 | Joint hemorrhage (HP:0005261) | 4.78154650 |
| 11 | Hyperglycinemia (HP:0002154) | 4.75260143 |
| 12 | Hyperammonemia (HP:0001987) | 4.66822033 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.65861218 |
| 14 | Epidermoid cyst (HP:0200040) | 4.42170417 |
| 15 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.34627510 |
| 16 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.33379453 |
| 17 | Abnormality of methionine metabolism (HP:0010901) | 4.33275216 |
| 18 | Abnormality of the common coagulation pathway (HP:0010990) | 4.33138807 |
| 19 | Ketosis (HP:0001946) | 4.28394020 |
| 20 | Hyperglycinuria (HP:0003108) | 4.27877519 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.27316363 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.27283990 |
| 23 | Abnormality of glycine metabolism (HP:0010895) | 4.19018144 |
| 24 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.19018144 |
| 25 | Fat malabsorption (HP:0002630) | 4.09801502 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 4.02244904 |
| 27 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.93577268 |
| 28 | Abnormality of complement system (HP:0005339) | 3.80636858 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.79097266 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.71039408 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.64521273 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.52234310 |
| 33 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.42604279 |
| 34 | Nephritis (HP:0000123) | 3.39485603 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.33741993 |
| 36 | Hyperbilirubinemia (HP:0002904) | 3.32129412 |
| 37 | Abnormality of serum amino acid levels (HP:0003112) | 3.28498803 |
| 38 | Delayed CNS myelination (HP:0002188) | 3.22093643 |
| 39 | Abnormality of nucleobase metabolism (HP:0010932) | 3.19254144 |
| 40 | Fair hair (HP:0002286) | 3.12539658 |
| 41 | Steatorrhea (HP:0002570) | 3.09626106 |
| 42 | Ketoacidosis (HP:0001993) | 3.05272591 |
| 43 | Hepatocellular carcinoma (HP:0001402) | 2.94268361 |
| 44 | Spontaneous abortion (HP:0005268) | 2.92878072 |
| 45 | Hypochromic microcytic anemia (HP:0004840) | 2.86165832 |
| 46 | Metabolic acidosis (HP:0001942) | 2.83610477 |
| 47 | Myocardial infarction (HP:0001658) | 2.82592677 |
| 48 | Abnormality of purine metabolism (HP:0004352) | 2.82092582 |
| 49 | Hyperphosphaturia (HP:0003109) | 2.80615694 |
| 50 | Lethargy (HP:0001254) | 2.76091923 |
| 51 | Gout (HP:0001997) | 2.71864422 |
| 52 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.69758254 |
| 53 | Dicarboxylic aciduria (HP:0003215) | 2.69758254 |
| 54 | Skin nodule (HP:0200036) | 2.67801637 |
| 55 | Vascular calcification (HP:0004934) | 2.65728594 |
| 56 | Systemic lupus erythematosus (HP:0002725) | 2.64419357 |
| 57 | Osteomalacia (HP:0002749) | 2.63105834 |
| 58 | Cerebral edema (HP:0002181) | 2.51433405 |
| 59 | Acanthocytosis (HP:0001927) | 2.47910205 |
| 60 | Glomerulonephritis (HP:0000099) | 2.47635588 |
| 61 | Irritability (HP:0000737) | 2.46193215 |
| 62 | Spastic diplegia (HP:0001264) | 2.44534759 |
| 63 | Neonatal onset (HP:0003623) | 2.42379880 |
| 64 | Hypokalemic alkalosis (HP:0001949) | 2.39405509 |
| 65 | Increased circulating renin level (HP:0000848) | 2.38405930 |
| 66 | Hypoglycemic seizures (HP:0002173) | 2.37497282 |
| 67 | Metabolic alkalosis (HP:0200114) | 2.36464291 |
| 68 | Malnutrition (HP:0004395) | 2.34741011 |
| 69 | Cardiovascular calcification (HP:0011915) | 2.33956263 |
| 70 | Abnormal gallbladder morphology (HP:0012437) | 2.33658311 |
| 71 | Mitral stenosis (HP:0001718) | 2.31094772 |
| 72 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.28734349 |
| 73 | Cholelithiasis (HP:0001081) | 2.27283535 |
| 74 | Abnormality of vitamin metabolism (HP:0100508) | 2.26593305 |
| 75 | Generalized hypopigmentation of hair (HP:0011358) | 2.22678318 |
| 76 | Generalized aminoaciduria (HP:0002909) | 2.22448759 |
| 77 | Abnormal gallbladder physiology (HP:0012438) | 2.21266869 |
| 78 | Cholecystitis (HP:0001082) | 2.21266869 |
| 79 | Abnormal biliary tract physiology (HP:0012439) | 2.19853784 |
| 80 | Bile duct proliferation (HP:0001408) | 2.19853784 |
| 81 | Abnormal urine phosphate concentration (HP:0012599) | 2.17629215 |
| 82 | Amyloidosis (HP:0011034) | 2.16968081 |
| 83 | Pancreatitis (HP:0001733) | 2.16304446 |
| 84 | Menorrhagia (HP:0000132) | 2.15495435 |
| 85 | Late onset (HP:0003584) | 2.15435523 |
| 86 | Vomiting (HP:0002013) | 2.15328943 |
| 87 | Esophageal varix (HP:0002040) | 2.13634498 |
| 88 | Enlarged kidneys (HP:0000105) | 2.13548379 |
| 89 | Gingival bleeding (HP:0000225) | 2.12300286 |
| 90 | Sensorimotor neuropathy (HP:0007141) | 2.11817228 |
| 91 | Brushfield spots (HP:0001088) | 2.11300848 |
| 92 | Alkalosis (HP:0001948) | 2.10923856 |
| 93 | Reduced antithrombin III activity (HP:0001976) | 2.08365655 |
| 94 | Arthropathy (HP:0003040) | 2.05694774 |
| 95 | Rickets (HP:0002748) | 2.03223684 |
| 96 | Opisthotonus (HP:0002179) | 2.02955497 |
| 97 | Thrombophlebitis (HP:0004418) | 2.02928654 |
| 98 | Pulmonary embolism (HP:0002204) | 2.02801063 |
| 99 | Abnormal urine output (HP:0012590) | 2.02313428 |
| 100 | Potter facies (HP:0002009) | 2.00337031 |
| 101 | Facial shape deformation (HP:0011334) | 2.00337031 |
| 102 | Neonatal hypoglycemia (HP:0001998) | 1.99605008 |
| 103 | Poikilocytosis (HP:0004447) | 1.94273391 |
| 104 | Abnormality of the gallbladder (HP:0005264) | 1.92039778 |
| 105 | Joint swelling (HP:0001386) | 1.91680912 |
| 106 | Proximal tubulopathy (HP:0000114) | 1.91538370 |
| 107 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.90945691 |
| 108 | Hemorrhage of the eye (HP:0011885) | 1.90636992 |
| 109 | Hypophosphatemic rickets (HP:0004912) | 1.90424034 |
| 110 | Renal cortical cysts (HP:0000803) | 1.90379671 |
| 111 | Hydroxyprolinuria (HP:0003080) | 1.90228680 |
| 112 | Abnormality of proline metabolism (HP:0010907) | 1.90228680 |
| 113 | Purpura (HP:0000979) | 1.87823093 |
| 114 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.87697416 |
| 115 | Abnormal cartilage morphology (HP:0002763) | 1.86847355 |
| 116 | Increased purine levels (HP:0004368) | 1.86263471 |
| 117 | Hyperuricemia (HP:0002149) | 1.86263471 |
| 118 | Glycosuria (HP:0003076) | 1.84690348 |
| 119 | Abnormality of urine glucose concentration (HP:0011016) | 1.84690348 |
| 120 | Abnormality of iron homeostasis (HP:0011031) | 1.83996142 |
| 121 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.83383216 |
| 122 | Polyuria (HP:0000103) | 1.82722367 |
| 123 | Hypokalemia (HP:0002900) | 1.77548498 |
| 124 | Hypomagnesemia (HP:0002917) | 1.75991294 |
| 125 | Abnormality of renal excretion (HP:0011036) | 1.75006249 |
| 126 | Hypothermia (HP:0002045) | 1.71046769 |
| 127 | Hyperactive renin-angiotensin system (HP:0000841) | 1.68805073 |
| 128 | Gangrene (HP:0100758) | 1.66140019 |
| 129 | Cerebral palsy (HP:0100021) | 1.65786084 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.52474885 |
| 2 | FGFR4 | 4.61005620 |
| 3 | SIK1 | 4.38414449 |
| 4 | ERN1 | 4.16657100 |
| 5 | OXSR1 | 3.81154546 |
| 6 | TAOK3 | 3.14663161 |
| 7 | INSRR | 2.99421076 |
| 8 | ERBB4 | 2.91659853 |
| 9 | WNK4 | 2.88816486 |
| 10 | MAP4K2 | 2.43802017 |
| 11 | PIK3CA | 2.41369881 |
| 12 | ADRBK2 | 2.28065966 |
| 13 | MAP2K4 | 2.27324894 |
| 14 | MST1R | 2.24163811 |
| 15 | TXK | 2.16962100 |
| 16 | PKN2 | 2.01357541 |
| 17 | MAPK11 | 1.92932083 |
| 18 | ZAK | 1.87366670 |
| 19 | PIK3CG | 1.86559675 |
| 20 | FLT3 | 1.85856390 |
| 21 | TYK2 | 1.66818558 |
| 22 | BCR | 1.63051697 |
| 23 | ABL2 | 1.61299071 |
| 24 | PINK1 | 1.52448709 |
| 25 | LATS1 | 1.52217975 |
| 26 | DAPK2 | 1.47240059 |
| 27 | MUSK | 1.43874606 |
| 28 | NEK9 | 1.41682748 |
| 29 | TRIB3 | 1.38351950 |
| 30 | STK39 | 1.37002478 |
| 31 | KDR | 1.34373649 |
| 32 | FRK | 1.31806442 |
| 33 | CAMKK2 | 1.31766740 |
| 34 | BMPR1B | 1.31113113 |
| 35 | NTRK3 | 1.25542166 |
| 36 | PTK6 | 1.23774487 |
| 37 | JAK2 | 1.22308009 |
| 38 | FGFR2 | 1.19523647 |
| 39 | GRK6 | 1.18803302 |
| 40 | STK38L | 1.17085454 |
| 41 | MAP3K12 | 1.16357471 |
| 42 | TLK1 | 1.16115509 |
| 43 | PRKAA2 | 1.16024927 |
| 44 | MAP3K7 | 1.15088422 |
| 45 | PAK3 | 1.14095653 |
| 46 | IRAK3 | 1.11693112 |
| 47 | MYLK | 1.08600426 |
| 48 | MAP3K14 | 1.06759510 |
| 49 | FER | 1.06756366 |
| 50 | MAPK4 | 1.05398613 |
| 51 | MAPKAPK3 | 1.04109430 |
| 52 | TBK1 | 1.04071862 |
| 53 | MAP2K3 | 1.03724407 |
| 54 | MAPK15 | 1.00390344 |
| 55 | ERBB2 | 0.96680075 |
| 56 | CASK | 0.95897170 |
| 57 | JAK1 | 0.93069650 |
| 58 | PRKCZ | 0.89941409 |
| 59 | STK16 | 0.89593012 |
| 60 | PRKACA | 0.89190103 |
| 61 | OBSCN | 0.88837403 |
| 62 | TRIM28 | 0.86898145 |
| 63 | MAP3K3 | 0.85959494 |
| 64 | MAPK12 | 0.83715210 |
| 65 | TIE1 | 0.82722248 |
| 66 | CDK6 | 0.80569682 |
| 67 | PRKCE | 0.79440793 |
| 68 | MAP3K10 | 0.78460777 |
| 69 | MAP3K11 | 0.76931376 |
| 70 | MET | 0.76484208 |
| 71 | NUAK1 | 0.76406727 |
| 72 | PRKACG | 0.75144408 |
| 73 | MAP3K4 | 0.73781623 |
| 74 | GSK3A | 0.73290205 |
| 75 | CAMK2G | 0.72595822 |
| 76 | MAP2K6 | 0.72281302 |
| 77 | DYRK1B | 0.72064702 |
| 78 | EPHB1 | 0.71937165 |
| 79 | CSK | 0.71391234 |
| 80 | PRKG1 | 0.70456610 |
| 81 | PRKAA1 | 0.68879565 |
| 82 | EPHA3 | 0.66604628 |
| 83 | SGK3 | 0.65039374 |
| 84 | TGFBR2 | 0.63965268 |
| 85 | CSNK1G1 | 0.63893186 |
| 86 | ACVR1B | 0.63801474 |
| 87 | IKBKE | 0.63004660 |
| 88 | ADRBK1 | 0.62992887 |
| 89 | MAPK7 | 0.62665271 |
| 90 | MAPK13 | 0.62556373 |
| 91 | PHKG2 | 0.62466371 |
| 92 | PHKG1 | 0.62466371 |
| 93 | SGK2 | 0.55978918 |
| 94 | GRK1 | 0.55415119 |
| 95 | CSNK1A1 | 0.55286219 |
| 96 | IRAK2 | 0.54072279 |
| 97 | CSNK1D | 0.53585691 |
| 98 | CSF1R | 0.51189895 |
| 99 | PDPK1 | 0.49709148 |
| 100 | STK38 | 0.49444857 |
| 101 | CDK4 | 0.48757538 |
| 102 | PRKCQ | 0.47848869 |
| 103 | IRAK1 | 0.47763179 |
| 104 | TNK2 | 0.46711559 |
| 105 | CAMK1D | 0.46295684 |
| 106 | TAOK2 | 0.45370889 |
| 107 | FGFR3 | 0.43886630 |
| 108 | SGK494 | 0.43618150 |
| 109 | SGK223 | 0.43618150 |
| 110 | EPHA4 | 0.43462464 |
| 111 | PBK | 0.43283915 |
| 112 | PTK2 | 0.42786911 |
| 113 | IGF1R | 0.41925362 |
| 114 | CAMKK1 | 0.41139918 |
| 115 | AKT3 | 0.40339585 |
| 116 | MAP3K5 | 0.39921762 |
| 117 | PRKCG | 0.39378246 |
| 118 | MAP3K13 | 0.39102559 |
| 119 | IKBKB | 0.38645722 |
| 120 | RPS6KA3 | 0.37851221 |
| 121 | GRK7 | 0.37761179 |
| 122 | PRKCB | 0.37729647 |
| 123 | PDK4 | 0.36680420 |
| 124 | PDK3 | 0.36680420 |
| 125 | MAP2K7 | 0.36266402 |
| 126 | STK3 | 0.34868354 |
| 127 | BRSK2 | 0.34121940 |
| 128 | ERBB3 | 0.33964440 |
| 129 | CAMK1 | 0.33551025 |
| 130 | MAP3K6 | 0.32022111 |
| 131 | MAP2K1 | 0.31462806 |
| 132 | SGK1 | 0.31088202 |
| 133 | EIF2AK3 | 0.30628981 |
| 134 | PKN1 | 0.30527070 |
| 135 | PRKACB | 0.30521233 |
| 136 | WNK3 | 0.30107886 |
| 137 | RIPK1 | 0.30048735 |
| 138 | PDK1 | 0.29758473 |
| 139 | CSNK1G3 | 0.29218899 |
| 140 | NLK | 0.28413460 |
| 141 | CSNK1G2 | 0.28002610 |
| 142 | EGFR | 0.26600900 |
| 143 | PRKCA | 0.26200430 |
| 144 | MAP2K2 | 0.25581032 |
| 145 | CAMK4 | 0.23897904 |
| 146 | MTOR | 0.23870521 |
| 147 | ABL1 | 0.23533400 |
| 148 | RET | 0.21191720 |
| 149 | MAP3K1 | 0.21073970 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.47986149 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.54802984 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.40484195 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.34039632 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.05635217 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.69303164 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.68434591 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.68343677 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.65223485 |
| 10 | * Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.50298189 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47287918 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.42735407 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.34815637 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.20228446 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.14106714 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.10560668 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.96593850 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.95587281 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.94354090 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.94325829 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.91875224 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.82364879 |
| 23 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.79624794 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.77023820 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.75577194 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.74062107 |
| 27 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.73828495 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.72845295 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.70319370 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.70244267 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.66634018 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58035315 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.54902017 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.51586846 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50644703 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.47406478 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.42064526 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.36230571 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.36108677 |
| 40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.35512064 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.32393441 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.27955108 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27645961 |
| 44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.20854119 |
| 45 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.17301461 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.16880492 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.13391203 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.09816310 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.08232378 |
| 50 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.07942883 |
| 51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.02393479 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.00314149 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.99693396 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99387138 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.96433967 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.92885534 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88985856 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.86898127 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.80416933 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.78618829 |
| 61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.69406156 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68287118 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68206725 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59967407 |
| 65 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.48480541 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46703855 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.46268338 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.33901190 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.33084554 |
| 70 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.25825061 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25305872 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.23472957 |
| 73 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22341567 |
| 74 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.21658011 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18675439 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.18653545 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17735473 |
| 78 | Pertussis_Homo sapiens_hsa05133 | 0.14702908 |
| 79 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.11082902 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.05670747 |
| 81 | Phototransduction_Homo sapiens_hsa04744 | 0.01187016 |
| 82 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.2571051 |
| 83 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2563240 |
| 84 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.2467866 |
| 85 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2404360 |
| 86 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2342032 |
| 87 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2244691 |
| 88 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2139634 |
| 89 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1995218 |
| 90 | Parkinsons disease_Homo sapiens_hsa05012 | -0.1859004 |
| 91 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1850335 |
| 92 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.1831682 |
| 93 | Hepatitis C_Homo sapiens_hsa05160 | -0.1827233 |
| 94 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.1784897 |
| 95 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1768224 |
| 96 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1731441 |
| 97 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1674117 |
| 98 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1558407 |
| 99 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1491727 |
| 100 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1490295 |
| 101 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1367446 |
| 102 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | -0.1174878 |
| 103 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1120041 |
| 104 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.0908670 |
| 105 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | -0.0880654 |
| 106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0879649 |
| 107 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0610337 |
| 108 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0377525 |
| 109 | Mineral absorption_Homo sapiens_hsa04978 | -0.0260211 |
| 110 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0219004 |
| 111 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.0171918 |
| 112 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0132486 |
| 113 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0064728 |

